We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
29 hedge funds and large institutions have $2.45M invested in CASI Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
4% less capital invested
Capital invested by funds: $2.56M → $2.45M (-$115K)
6% less funds holding
Funds holding: 31 → 29 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$19.6K |
| 2 |
WSC
Wellington Shields & Co
New York
|
+$17.7K |
| 3 |
Renaissance Technologies
New York
|
+$9.55K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.34K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$636 |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17.7K |
| 2 |
Goldman Sachs
New York
|
-$5.96K |
| 3 |
WSCM
Wellington Shields Capital Management
New York
|
-$4.54K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$988 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$593 |
